-

Thermo Fisher Scientific Introduces Fully Integrated Multimodal Analytical Scanning Transmission Electron Microscope to Advance Novel Research in Materials Science

Thermo Scientific Iliad integrates electron energy loss spectroscopy (EELS) and NanoPulser electrostatic beam blanker to improve insights at the atomic level

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, introduced a groundbreaking transmission electron microscope to a packed room of attendees at the recent European Microscopy Congress 2024 in Copenhagen, Denmark. As a fully integrated multimodal analytical solution, the Thermo Scientific™ Iliad™ (Scanning) Transmission Electron Microscope, (S)TEM, gives scientific pioneers deeper insights about the chemical nature of the most sophisticated modern materials, down to the atomic level.

Iliad (S)TEM leverages Thermo Fisher's long history of innovation in scanning transmission electron microscopy, integrating multiple technological modalities into a seamless and user-friendly workflow.

“A revolutionary new platform like this only comes around once in a decade,” said David Wall, vice president and general manager of Materials Science at Thermo Fisher Scientific. “Beginning with its unveiling at EMC, Iliad has already received a positive and energetic reception from researchers and industry leaders across the globe. This is the culmination of years of investment and hard work, but in many ways it’s just the beginning of unlocking the full potential of integrated microscopy technology.”

Leading-edge integration of Iliad hardware and software

Iliad (S)TEM is featuring the new Thermo Fisher Scientific EELS Spectrometer and Energy Filter, as well as the NanoPulser — the new electrostatic beam blanker for the electron dose optimization. Multimodality and the integration of energy dispersive spectroscopy (EDS), EELS and the NanoPulser ensures the advanced and effective approach for precise chemical and structural investigations of broad classes of modern materials.

Iliad is fully controlled with the Thermo Scientific Velox software ecosystem for both spectroscopy and imaging, making the most challenging experiments now accessible to every user. Nearly every component in the Iliad platform can be accessed via Python scripting using Autoscript, opening the possibility of advanced control of the microscope, as well as the adoption of AI-based data collection and processing strategies. The solid interlink of the core modalities of modern (S)TEM enables smooth and reliable workflows for scientists.

Infused with customer insight

Professor Jo Verbeeck, co-leader of Electron Microscopy for Materials Science (EMAT) at the University of Antwerp in Belgium, collaborated on the development of Iliad with the special focus on data quantification. “It’s one thing to write papers on electron energy loss spectroscopy (EELS) quantification, it is far more exciting to see these ideas also implemented in a product that will really change the user experience and reproducibility of EELS,” says Professor Verbeeck, a renowned leader in EELS.

With Iliad, Thermo Fisher Scientific is opening a new chapter of advanced analytical (S)TEM. This completely integrated technology will enable scientists across broad academic and technology sectors to solve scientific problems that make the world healthier, cleaner and safer.

To learn more about Iliad, please visit our website.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media Contact Information:
Alex Runner
Thermo Fisher Scientific
alex.runner@thermofisher.com

Media Contact Information:
Jessika Parry, Greenough
419-266-4016
jparry@greenoughagency.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Media Contact Information:
Alex Runner
Thermo Fisher Scientific
alex.runner@thermofisher.com

Media Contact Information:
Jessika Parry, Greenough
419-266-4016
jparry@greenoughagency.com

More News From Thermo Fisher

Thermo Fisher Scientific Opens U.S. Flagship Bioprocess Design Center to Accelerate the Delivery of Life-changing Therapies

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the opening of its flagship U.S. Bioprocess Design Center (BDC) at the company’s Plainville, Mass., site, expanding the facility to support customers in developing and scaling biologics. The new center brings together advanced bioproduction capabilities and hands-on collaboration to help customers accelerate process development and bring transformative therapies to patients faste...

Thermo Fisher Scientific to Host Investor Day

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will hold its 2026 Investor Day on Wednesday, May 20, 2026, starting at 9:00 a.m. ET in New York City. The format will feature presentations by members of Thermo Fisher Scientific’s senior management team and conclude with a Q&A session. The live webcast of the presentation can be accessed via the Investors section of our website, https://ir.thermofisher.com. A replay of the webc...

Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has signed a definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food...
Back to Newsroom